1. Home
  2. BIO vs CX Comparison

BIO vs CX Comparison

Compare BIO & CX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$299.66

Market Cap

8.2B

Sector

Industrials

ML Signal

HOLD

Logo Cemex S.A.B. de C.V. Sponsored ADR

CX

Cemex S.A.B. de C.V. Sponsored ADR

HOLD

Current Price

$11.69

Market Cap

14.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIO
CX
Founded
1952
1906
Country
United States
Mexico
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Building Materials
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
14.7B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
BIO
CX
Price
$299.66
$11.69
Analyst Decision
Strong Buy
Buy
Analyst Count
4
7
Target Price
$358.50
$10.95
AVG Volume (30 Days)
158.4K
7.4M
Earning Date
10-29-2025
10-28-2025
Dividend Yield
N/A
0.76%
EPS Growth
N/A
231.88
EPS
N/A
0.09
Revenue
$2,557,500,000.00
$15,869,840,000.00
Revenue This Year
$1.77
$2.25
Revenue Next Year
$2.30
$5.11
P/E Ratio
N/A
$11.83
Revenue Growth
N/A
N/A
52 Week Low
$211.43
$4.89
52 Week High
$373.69
$11.57

Technical Indicators

Market Signals
Indicator
BIO
CX
Relative Strength Index (RSI) 38.91 74.38
Support Level $307.08 $10.79
Resistance Level $319.50 $11.86
Average True Range (ATR) 8.30 0.27
MACD -2.08 0.07
Stochastic Oscillator 2.51 87.67

Price Performance

Historical Comparison
BIO
CX

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About CX Cemex S.A.B. de C.V. Sponsored ADR

Cemex SAB de CV is a ready-mix concrete company that mainly engaged in activities that are oriented to the construction industry, mainly through the production, marketing, sale, and distribution of cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and also provide related services and reliable construction-related services to customers and communities and maintain business relationships in more than 60 countries throughout the world. The company operates in different parts of the world, with operations in Mexico, the United States, the EMEA region and the SCA&C region.

Share on Social Networks: